<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160-pharmaceutics-12-00688">
 <label>160.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rayess</surname>
    <given-names>H.M.</given-names>
   </name>
   <name>
    <surname>Xi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Garshott</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Brownell</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Yoo</surname>
    <given-names>G.H.</given-names>
   </name>
   <name>
    <surname>Callaghan</surname>
    <given-names>M.U.</given-names>
   </name>
   <name>
    <surname>Fribley</surname>
    <given-names>A.M.</given-names>
   </name>
  </person-group>
  <article-title>Benzethonium chloride activates ER stress and reduces proliferation in HNSCC</article-title>
  <source>Oral Oncol.</source>
  <year>2018</year>
  <volume>76</volume>
  <fpage>27</fpage>
  <lpage>33</lpage>
  <pub-id pub-id-type="doi">10.1016/j.oraloncology.2017.11.018</pub-id>
  <pub-id pub-id-type="pmid">29290283</pub-id>
 </element-citation>
</ref>
